HBIMEDICAL ApS — Credit Rating and Financial Key Figures
Credit rating
Company information
About HBIMEDICAL ApS
HBIMEDICAL ApS (CVR number: 36426063) is a company from FREDERIKSSUND. The company recorded a gross profit of -63.4 kDKK in 2023. The operating profit was -63.4 kDKK, while net earnings were -67.5 kDKK. The profitability of the company measured by Return on Assets (ROA) was -17.5 %, which can be considered poor and Return on Equity (ROE) was -39.4 %, which can be considered poor. The equity ratio, a key indicator for solidity, stood at 54.7 %, a level that can be considered to be modest. This means a balanced mix of debt and equity financing its assets—a typical operational level for many companies. HBIMEDICAL ApS's liquidity measured by quick ratio was 1.2 which is at a high level. Thus, the company is in a strong financial position, with liquid assets surpassing current liabilities. It is well-prepared to cover short-term financial obligations.
Financial information
See financialsGross profit (kDKK)
EBIT (kDKK)
Profitability
Solidity
Key figures (kDKK)
See financials2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Volume | |||||
Net sales | |||||
Gross profit | 153.92 | 82.96 | 125.29 | 38.95 | -63.42 |
EBIT | 117.79 | 78.13 | 119.38 | 38.95 | -63.42 |
Net earnings | 117.79 | 78.13 | 118.84 | 36.26 | -67.54 |
Shareholders equity total | 21.81 | 99.94 | 218.78 | 205.04 | 137.50 |
Balance sheet total (assets) | 224.91 | 306.97 | 588.08 | 475.34 | 251.31 |
Net debt | 107.72 | -21.80 | |||
Profitability | |||||
EBIT-% | |||||
ROA | 48.7 % | 29.4 % | 26.7 % | 7.3 % | -17.5 % |
ROE | 127.6 % | 128.3 % | 74.6 % | 17.1 % | -39.4 % |
ROI | 74.8 % | 68.1 % | 74.9 % | 18.3 % | -36.8 % |
Economic value added (EVA) | 122.81 | 77.03 | 114.36 | 25.92 | -70.80 |
Solvency | |||||
Equity ratio | 54.2 % | 32.6 % | 37.2 % | 43.1 % | 54.7 % |
Gearing | 493.9 % | ||||
Relative net indebtedness % | |||||
Liquidity | |||||
Quick ratio | 0.9 | 1.0 | 1.3 | 1.3 | 1.2 |
Current ratio | 2.1 | 1.4 | 1.6 | 1.7 | 2.1 |
Cash and cash equivalents | 21.80 | ||||
Capital use efficiency | |||||
Trade debtors turnover (days) | |||||
Net working capital % | |||||
Credit risk | |||||
Credit rating | BBB | BBB | BBB | BBB | BB |
Variable visualization
Companies in the same industry
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.